# Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPD

> **NCT02683109** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 221 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** FDC of tiotropium + olodaterol
- **DRUG:** Placebo
- **DRUG:** Tiotropium
- **DRUG:** Olodaterol

## Key facts

- **NCT ID:** NCT02683109
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-08
- **Primary completion:** 2017-01-09
- **Final completion:** 2017-01-30
- **Target enrollment:** 221 (ACTUAL)
- **Last updated:** 2018-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02683109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02683109, "Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPD". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02683109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*